Japan authorizes Israeli medicine for Parkinson’s
By Anav Silverman JERUSALEM (TNA) — Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan. The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 […]
Japan authorizes Israeli medicine for Parkinson’s Read More »
International, Middle East, Science, Medicine, & Education




